Skip to main content

Genentech — the world’s first biotech startup — was founded in 1976 in the San Francisco Bay Area. For more than 45 years, Genentech has pursued groundbreaking science to discover and develop innovative medicines for people facing serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. We invest more in research and development than any other health care company to fuel the future of scientific discovery.  We remain committed to finding treatments for life-threatening and difficult-to-treat conditions such as cancer, autoimmune conditions, and Alzheimer’s disease as well as retinal disorders such as geographic atrophy and diabetic macular edema.